πŸ‡ΊπŸ‡Έ FDA
Patent

US 9446080

Compositions and methods

granted A61KA61K35/37A61K35/74

Quick answer

US patent 9446080 (Compositions and methods) held by Seres Therapeutics, Inc. expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Seres Therapeutics, Inc.
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K35/37, A61K35/74, A61K35/741, A61K35/742